News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Metabolix, Inc. Signs Letter of Intent With Antibióticos for Production of Mirel Biopolymer Resin


7/27/2012 9:49:38 AM

CAMBRIDGE, Mass. & LEON, Spain--(BUSINESS WIRE)--July 26, 2012--Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that it has signed a letter of intent (“LOI”) with Antibióticos S.A. for production of MirelTM biopolymer resin at its manufacturing facility in Leon, Spain.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES